International Journal of Critical Illness and Injury Science

EXPERT COMMENTARY
Year
: 2017  |  Volume : 7  |  Issue : 1  |  Page : 8--11

Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?


Noel B Martins1, Kimberly J Chaput1, Stanislaw P Stawicki2, Ronak Modi1 
1 Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA
2 Department of Research and Innovation, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA

Correspondence Address:
Stanislaw P Stawicki
Department of Research and Innovation, St. Luke's University Health Network, Bethlehem, Pennsylvania
USA




How to cite this article:
Martins NB, Chaput KJ, Stawicki SP, Modi R. Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?.Int J Crit Illn Inj Sci 2017;7:8-11


How to cite this URL:
Martins NB, Chaput KJ, Stawicki SP, Modi R. Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?. Int J Crit Illn Inj Sci [serial online] 2017 [cited 2017 Jul 23 ];7:8-11
Available from: http://www.ijciis.org/article.asp?issn=2229-5151;year=2017;volume=7;issue=1;spage=8;epage=11;aulast=Martins;type=0